A public interest litigation is currently before India’s Supreme Court which challenges the drive to commercialise the growing of genetically modified (GM) mustard in India. On 26 October 2022, however, the country’s apex regulatory body – the Genetic Engineering Appraisal Committee – sanctioned commercialisation of the crop.
https://countercurrents.org/2022/10/indias-gm-mustard-and-the-30-year-path-to-food-tyranny/
The central government has in the past stated commercialisation will not go ahead prior to the court’s decision, but this remains to be seen.
Approval is a significant moment for the agri biotech industry, not least because GM mustard can be regarded as a pioneering crop that could open the doors to a range of other GM food crops that are in the pipeline.
At this point, only one GM crop is legally cultivated in India, Bt cotton – designed to resist certain pests. Prominent policy makers and lobbyists have been claiming that, due to the success of Bt cotton, it should serve as a template for the introduction of GM food crops.
But this claim is not grounded in reality. Bt cotton has been far from successful and has caused immense hardship for cotton farmers (in fact, it is a template for a monumental catastrophe). This is evidentially supported by Prof Andrew Paul Gutierrez, Dr Hans R Herren and Dr Peter E Kenmore, internationally renowned agricultural researchers.
The article Agri Biotech Motivated by Monopoly Control (25 October 2022) lists these reports and describes how – through deception, scientific fraud, technological sleight of hand and regulatory jugglery – GM mustard is designed (once commercialised) to facilitate the process of (chemical-dependent) GM food crop cultivation in India.
28/10/2022